Callan JMB Inc - CJMB Real Price to Acquire Entire Company

Callan JMB Inc (CJMB) is developing a non-cyclical business producing medical equipment and consumables, where stable demand from hospitals ensures resilient cash flows. The company's financial standing relies on orthopedic center budgets and patent protection, while operating profit remains within a safe range. The market price of 4.10, as confirmed by the chart, underscores the macro-stability of Callan JMB Inc (CJMB), whose services are demanded by surgery regardless of economic cycles.

CJMB (Callan JMB Inc) Total Company Value history from 08/28/2026 to 10/27/2026

Callan JMB Inc.'s specialization in revenue optimization for US clinics makes its valuation dependent on the efficiency of capital management. Enterprise value modeling, which combines market capitalization with net debt, reflects the actual investment required for a full buyout of the business, allowing investors to distinguish temporary market noise from long-term shifts in the asset's fundamental value.

Competitor analysis for Callan JMB Inc

Intuitive Surgical, Inc. - Aggregate Business Value|DHR: Total Company Value|BDX - Real Price to Acquire Entire Company|STERIS plc (STE) - Enterprise Value|WST (westpharma.com) - Total Company Value|Total Company Value BAX|Real Price to Acquire Entire Company Masimo Corp|Stevanato - Enterprise Value|Total Enterprise Value Teleflex Corp (TFX)|MMSI - Enterprise Value|Business Value envistaco.com NVST|Enterprise Value ICUI (ICU Medical)|XRAY - Company Buyout Price|LMAT (LeMaitre) - Enterprise Value|AtriCure Medical (ATRC) - Real Price to Acquire Entire Company|STAA (STAAR Surgical Company) - Enterprise Value|Enterprise Value NAGE|Total Company Value ZimVie (ZIMV)|Total Company Value AngioDynamics Inc ANGO|Real Price to Acquire Entire Company Cerus Corp|Value Adjusted for Debt and Cash Teknova Inc TKNO|Enterprise Value MGRM (Monogram Technologies)|STSS: Company Buyout Price|Total Company Value infusystem.com|UTMD (Utah Medical Products Inc.) - Business Value|KRMD: Total Company Value|Company Buyout Price Nyxoah S.A (NYXH)|Real Price to Acquire Entire Company Microbot Medical Inc.|Aggregate Business Value PDEX (pro-dex.com)|Total Company Value Zentek|ELUT - Value Adjusted for Debt and Cash|Milestone Scientific Corp - Real Price to Acquire Entire Company|NXGL: Enterprise Value|RVP (retractable.com) - Total Company Value|harvardbioscience.com (HBIO) - Real Price to Acquire Entire Company|Enterprise Value FEMY (Femasys)|Total Enterprise Value MHUA|Total Company Value Predictive Oncology POAI|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)